Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)
Public ClinicalTrials.gov record NCT01134705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Clinical Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol (320 Mcg, Once Daily) in the Treatment of Perennial Allergic Rhinitis (PAR) in Adult and Adolescent Subjects (12 Years of Age and Older)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of perennial allergic rhinitis.
Study identification
- NCT ID
- NCT01134705
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 474 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Oct 2010 (Actual)
- Completion
- Oct 2010 (Actual)
- Last update posted
- May 23, 2012
2010
United States locations
- U.S. sites
- 35
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Clinical Study Site | Los Angeles | California | 90025 | — |
| Teva Clinical Study Site | Mission Viejo | California | 92691 | — |
| Teva Clinical Study Site | San Diego | California | 92123 | — |
| Teva Clinical Study Site | San Jose | California | 95117 | — |
| Teva Clinical Study Site | Miami | Florida | 33173 | — |
| Teva Clinical Study Site | Tallahassee | Florida | 32308 | — |
| Teva Clinical Study Site | Lilburn | Georgia | 30047 | — |
| Teva Clinical Study Site | Indianapolis | Indiana | 46208 | — |
| Teva Clinical Study Site | Bangor | Maine | 04401 | — |
| Teva Clinical Study Site | Bethesda | Maryland | 20814 | — |
| Teva Clinical Study Site | Rolla | Missouri | 65401 | — |
| Teva Clinical Study Site | St Louis | Missouri | 63141 | — |
| Teva Clinical Study Site | Brick | New Jersey | 08724 | — |
| Teva Clinical Study Site | Raleigh | North Carolina | 27607 | — |
| Teva Clinical Study Site | Winston-Salem | North Carolina | 27103 | — |
| Teva Clinical Study Site | Canton | Ohio | 44718 | — |
| Teva Clinical Study Site | Medford | Oregon | 97504 | — |
| Teva Clinical Study Site | Portland | Oregon | 97213 | — |
| Teva Clinical Study Site | Blue Bell | Pennsylvania | 19422 | — |
| Teva Clinical Study Site | Upland | Pennsylvania | 19013 | — |
| Teva Clinical Study Site | Providence | Rhode Island | 02906 | — |
| Teva Clinical Study Site | Charleston | South Carolina | 29407 | — |
| Teva Clinical Study Site | Spartanburg | South Carolina | 29303 | — |
| Teva Clinical Study Site | Austin | Texas | 78731 | — |
| Teva Clinical Study Site | Dallas | Texas | 75230 | — |
| Teva Clinical Study Site | Dallas | Texas | 75231 | — |
| Teva Clinical Study Site | Fort Worth | Texas | 76132 | — |
| Teva Clinical Study Site | Katy | Texas | 77450 | — |
| Teva Clinical Study Site | New Braunfels | Texas | 78130 | — |
| Teva Clinical Study Site | San Antonio | Texas | 78229 | — |
| Teva Clinical Study Site | San Antonio | Texas | 78829 | — |
| Teva Clinical Study Site | Waco | Texas | 76712 | — |
| Teva Clinical Study Site | Newport News | Virginia | 23606 | — |
| Teva Clinical Study Site | Richmond | Virginia | 23233 | — |
| Teva Clinical Study Site | Bellevue | Washington | 68123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01134705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01134705 live on ClinicalTrials.gov.